Literature DB >> 2479432

The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

K T Preissner1.   

Abstract

Vitronectin (= complement S-protein) belongs to the group of structurally and functionally homologous adhesive proteins (fibrinogen, fibronectin, von Willebrand factor) which are essential in the procoagulant phase of the hemostatic system, interacting with platelets and the vessel wall. In addition to a structural motif in vitronectin responsible for this interaction (cell attachment domain) other functional domains in the protein molecule exist that contribute to its multifunctional role as regulator in the immune system (complement) as well as in fibrinolysis. These various activities and the ubiquitous distribution of vitronectin in the organism are discussed with regard to structure-function relationships of the protein molecule. Vitronectin may thus provide a conceptual molecular link between cell adhesion, humoral immune response and the hemostatic system, particularly at the blood-vessel wall interphase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479432     DOI: 10.1007/bf00349063

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  128 in total

1.  Exposure of binding sites for vitronectin on platelets following stimulation.

Authors:  P Thiagarajan; K L Kelly
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

2.  Effects of a serum spreading factor on growth and morphology of cells in serum-free medium.

Authors:  D Barnes; R Wolfe; G Serrero; D McClure; G Sato
Journal:  J Supramol Struct       Date:  1980

3.  A novel beta-endorphin binding protein. Complement S protein (= vitronectin) exhibits specific non-opioid binding sites for beta-endorphin upon interaction with heparin or surfaces.

Authors:  A Hildebrand; K T Preissner; G Müller-Berghaus; H Teschemacher
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

4.  Heparin with two binding sites for antithrombin or platelet factor 4.

Authors:  R E Jordan; L V Favreau; E H Braswell; R D Rosenberg
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

5.  Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.

Authors:  S Schönermark; E W Rauterberg; M L Shin; S Löke; D Roelcke; G M Hänsch
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

6.  Isolation of human serum spreading factor.

Authors:  D W Barnes; J Silnutzer
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

7.  Mediation of adherence of streptococci to human endothelial cells by complement S protein (vitronectin).

Authors:  P Valentin-Weigand; J Grulich-Henn; G S Chhatwal; G Müller-Berghaus; H Blobel; K T Preissner
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

8.  Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex.

Authors:  K T Preissner; E Anders; J Grulich-Henn; G Müller-Berghaus
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

9.  Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).

Authors:  P J Declerck; M De Mol; M C Alessi; S Baudner; E P Pâques; K T Preissner; G Müller-Berghaus; D Collen
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

10.  Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

View more
  12 in total

1.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

Review 2.  Evidence for an extra-cellular function for protein kinase A.

Authors:  S Shaltiel; I Schvartz; B Korc-Grodzicki; T Kreizman
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

3.  Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.

Authors:  C L Gladson; D A Cheresh
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 4.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

5.  Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

6.  Osteopontin--a possible anchor of osteoclasts to bone.

Authors:  F P Reinholt; K Hultenby; A Oldberg; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Analyzing the Effect of Vitronectin on Cell Growth and Mesenchymal-Epithelial Transition of Pulmonary Fibroblast Cells.

Authors:  Ya Zeng; Jiahua Yu; Mina Liu; Qin Zhang; Xuwei Cai
Journal:  Lung       Date:  2021-08-20       Impact factor: 2.584

8.  Complement inhibition by human vitronectin involves non-heparin binding domains.

Authors:  M Sheehan; C A Morris; B A Pussell; J A Charlesworth
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  Interaction between complement proteins C5b-7 and erythrocyte membrane sialic acid.

Authors:  P Marshall; A Hasegawa; E A Davidson; V Nussenzweig; M Whitlow
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

10.  Proteomic analysis of human plasma in chronic rheumatic mitral stenosis reveals proteins involved in the complement and coagulation cascade.

Authors:  Somaditya Mukherjee; Mashanipalya G Jagadeeshaprasad; Tanima Banerjee; Sudip K Ghosh; Monodeep Biswas; Santanu Dutta; Mahesh J Kulkarni; Sanjib Pattari; Arun Bandyopadhyay
Journal:  Clin Proteomics       Date:  2014-09-24       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.